OVID
Price:
$2.27
Market Cap:
$299.38M
Ovid Therapeutics Inc. is a biopharmaceutical firm dedicated to creating significant treatments for individuals and families impacted by neurological disorders across the United States. The company's robust pipeline features several key therapeutic candidates: OV101, a drug candidate currently undergoing Phase 2A clinical trials for Fragile X syndrome; OV329, an inhibitor targeting GABA aminotransferase, aimed at managing seizures linked to tuberous sclerosis complex and infantile spasms; and OV350, a small molecule developed to address various forms of epilepsy. Beyond these, Ovid is also advancing OV882, a short hairpin RNA (shRNA) gene therapy designed to treat Angelman syndrome, and OV81...[Read more]
Industry
Biotechnology
IPO Date
2017-05-05
Stock Exchange
NASDAQ
Ticker
OVID
According to Ovid Therapeutics Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 10.17. This represents a change of 35.41% compared to the average of 7.51 of the last 4 quarters.
The mean historical Current Ratio of Ovid Therapeutics Inc. over the last ten years is 10.22. The current 10.17 Current Ratio has changed 9.85% with respect to the historical average. Over the past ten years (40 quarters), OVID's Current Ratio was at its highest in in the September 2016 quarter at 21.76. The Current Ratio was at its lowest in in the June 2016 quarter at 0.
Average
10.22
Median
10.23
Minimum
3.39
Maximum
18.79
Discovering the peaks and valleys of Ovid Therapeutics Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 279.44%
Maximum Annual Current Ratio = 18.79
Minimum Annual Increase = -65.98%
Minimum Annual Current Ratio = 3.39
| Year | Current Ratio | Change |
|---|---|---|
| 2025 | 10.91 | 105.27% |
| 2024 | 5.32 | -44.35% |
| 2023 | 9.55 | -49.16% |
| 2022 | 18.79 | 45.99% |
| 2021 | 12.87 | 279.44% |
| 2020 | 3.39 | -55.23% |
| 2019 | 7.58 | 51.38% |
| 2018 | 5.01 | -65.98% |
| 2017 | 14.71 | 4.80% |
| 2016 | 14.04 | -53.88% |
The current Current Ratio of Ovid Therapeutics Inc. (OVID) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
8.59
5-year avg
11.49
10-year avg
10.22
Ovid Therapeutics Inc.’s Current Ratio is greater than Context Therapeutics Inc. (8.96), greater than MacroGenics, Inc. (1.90), greater than Clene Inc. (1.94), greater than Oramed Pharmaceuticals Inc. (6.45), less than Shattuck Labs, Inc. (22.06), less than ImageneBio Inc (18.39), greater than Connect Biopharma Holdings Limited (3.74), greater than InflaRx N.V. (4.16), less than Whitehawk Therapeutics Inc (11.36), less than Kalaris Therapeutics Inc (12.14),
| Company | Current Ratio | Market cap |
|---|---|---|
| 8.96 | $58.06M | |
| 1.90 | $262.52M | |
| 1.94 | $61.95M | |
| 6.45 | $158.79M | |
| 22.06 | $237.12M | |
| 18.39 | $67.67M | |
| 3.74 | $125.93M | |
| 4.16 | $130.74M | |
| 11.36 | $218.58M | |
| 12.14 | $88.28M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Ovid Therapeutics Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Ovid Therapeutics Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Current Ratio?
How can you use the Current Ratio?
What is Ovid Therapeutics Inc.'s Current Ratio?
How is the Current Ratio calculated for Ovid Therapeutics Inc. (OVID)?
What is the highest Current Ratio for Ovid Therapeutics Inc. (OVID)?
What is the 3-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?
What is the 5-year average Current Ratio for Ovid Therapeutics Inc. (OVID)?
How does the current Current Ratio for Ovid Therapeutics Inc. (OVID) compare to its historical average?